Results 201 to 210 of about 600,809 (212)

Postmarketing Surveillance

2003
openaire   +1 more source

Postmarketing surveillance evaluating the safety and effectiveness of golimumab in Japanese patients with rheumatoid arthritis

Modern Rheumatology, 2018
M. Kanbori, H. Suzuka, T. Yajima, E. Kishino, Ryuji Morishige, S. Momohara, A. Kawakami, M. Ota   +7 more
semanticscholar   +1 more source

Postmarketing surveillance: Statistics and augury

Journal of Chronic Diseases, 1984
openaire   +3 more sources

Safety and effectiveness of iguratimod in patients with rheumatoid arthritis: Final report of a 52-week, multicenter postmarketing surveillance study

Modern Rheumatology, 2019
T. Mimori, M. Harigai, T. Atsumi, T. Fujii, M. Kuwana, H. Matsuno, S. Momohara, S. Takei, N. Tamura, Y. Takasaki, Kazuhiko Yamamoto, S. Ikeuchi, S. Kushimoto, T. Koike   +13 more
semanticscholar   +1 more source

Rare side effects of alemtuzumab remind us of the need for postmarketing surveillance

Neurology, 2018
P. Muraro, N. Scolding, R. Fox
semanticscholar   +1 more source

Postmarket Surveillance

2013
openaire   +2 more sources

Postmarketing Drug Sureillance

Journal of Pharmaceutical Sciences, 1979
openaire   +3 more sources

Perioperative safety and hemostatic efficacy of Advate® in patients with hemophilia A in a postmarketing surveillance in Japan

International journal of hematology, 2018
K. Nogami, H. Takedani, M. Shima, A. Yoshioka, T. Matsushita, J. Takamatsu, M. Taki, K. Fukutake, Haruhiko Uchikawa, H. Takagi, M. Arai, W. Engl, A. Shirahata   +12 more
semanticscholar   +1 more source

Postmarket Surveillance Redux

Biomedical Safety & Standards, 2013
openaire   +2 more sources

Hysteroscopic Sterilization With Essure: Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance.

Obstetrics and Gynecology, 2017
J. Walter, Comeron W. Ghobadi, Emily L Hayman, Shuai Xu   +3 more
semanticscholar   +1 more source